CN100496562C - Medicinal wine for preventing and treating cerebral thrombosis diseases - Google Patents
Medicinal wine for preventing and treating cerebral thrombosis diseases Download PDFInfo
- Publication number
- CN100496562C CN100496562C CNB2004100781089A CN200410078108A CN100496562C CN 100496562 C CN100496562 C CN 100496562C CN B2004100781089 A CNB2004100781089 A CN B2004100781089A CN 200410078108 A CN200410078108 A CN 200410078108A CN 100496562 C CN100496562 C CN 100496562C
- Authority
- CN
- China
- Prior art keywords
- standby
- fructus
- hour
- soaked
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicinal wine for preventing and treating cardiac and cerebral vascular diseases is prepared with notoginseng, schisandra, haw, wolfberry fruit, safflower and white spirit in 40-60 % alcohol content in certain weight proportion. The medicinal wine contains wintercherry red essence, safflower red essence, carthamin, hyperoside, rutin, betaine, polysaccharide, coarse fat, coarse protein, vitamins, trace elements, etc. It has the functions of tonifying heart, resisting myocardial ischemia and myocardial infaction, resisting anoxia, dredging blood vessel, improving micro circulation, etc. and thus may be used in preventing and treating cardiac and cerebral vascular diseases.
Description
Technical field
The invention belongs to medical technical field, in particular to the medicated wine of a kind of prevention and treatment cerebral thrombosis disease.
Background technology
At present, cerebral thrombosis disease more and more threatens human beings'health, influences people's life and quality of life.Oral medication cerebral thrombosis disease medicine often has absorption difference, the slow weakness that takes effect, and intravenous drip has inconvenient worry.Often intravenous drip, people for the body constitution difference, because of absorbing and anti-pre-ability, because of the transfusion liquid different with the current potential of blood of human body, liquid directly enters blood not to be had under the prerequisite of equilibrium potential, can produce different charge attraction phenomenon, thereby can produce Electrostatic Absorption flocculation phenomenon, can produce precipitation when serious.This precipitation can increase thrombotic chance, can produce obstacle to blood vessel blood supply oxygen supply again.In addition, intravenous drip can increase infectious disease epidemic prevention risk again.
Summary of the invention
The objective of the invention is to overcome the shortcoming of above-mentioned prior art, the medicated wine of a kind of prevention and treatment cerebral thrombosis disease is proposed, above-mentioned disease can be accomplished with amusement and treatment, under the situation that diseases prevention is combined as a whole, improve middle-aged and elderly people life and quality of life, increase the life-span, in the amusement process of happiness, play the effect and the purpose of preventing and curing diseases, ethanol has the characteristics of easy molten water solublity and fat-soluble medicine, borrow capacity for liquor can make human body fully to drug absorption, can make the curative effect performance and the enhancing rapidly of medicine again, overcome inconvenience, drug absorption is poor, it is slow to take effect, increase the chance of other disease and the shortcoming of infectious disease epidemic prevention risk.
Crude drug of the present invention is selected Radix Notoginseng, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Lycii and Flos Carthami, contains nicotinic acid, linoleic acid, nicotinic acid, stearic acid, Palmic acid, arachidic acid, aminoacid; Physalin, safflower yellow, carthamone, hyperin, Quercetin, rutin; Betanin, polysaccharide, crude fat, crude protein, carotene, dimension B
1, the dimension B
2, dimension C, trace element etc.Physalin, safflower yellow, carthamone, hyperin, Quercetin, rutin is slight excited heart, heart tonifying, coronary blood flow increasing alleviates myocardial ischemia, arrhythmia; Blood vessel dilating, blood pressure lowering, dredging vascellum suppresses platelet aggregation and increases the fibrinolytic effect; The pregnant and unpregnancy uterus of excitement; Promote steatolysis, improve protease activities, blood fat reducing and alleviate the atherosclerosis effect; Circulation of qi promoting loose silt, promoting blood circulation to restore menstrual flow, collateral dredging.The supporing yang kidney-tonifying sperm-generating of nicotinic acid, linoleic acid, nicotinic acid, stearic acid, Palmic acid, arachidic acid, aminoacid and betanin improves immunologic function, promotes hemopoietic function, leukocyte increasing, strengthen the phagocytic activity of reticuloendothelial system, defying age, mutation, protect the liver, blood sugar lowering improves plasma testosterone level.Polysaccharide, crude fat, crude protein, carotene, dimension B
1, the dimension B
2, main body nutrition, the auxiliary immunity that improve of increasing such as dimension C, trace element.
The medicated wine of a kind of prevention of the present invention and treatment cerebral thrombosis disease is made up of following raw materials according medicine and proportioning: Radix Notoginseng 5-10 gram, Fructus Schisandrae Chinensis 20-40 gram, Fructus Crataegi 10-30 gram, Fructus Lycii 30-50 gram, Flos Carthami 1-4 gram, 1 liter of 40%-60% Chinese liquor, wherein Fructus Crataegi is bright product weight, all the other medicines are dry product weight.
The medicated wine compound method of the present invention's prevention and treatment cerebral thrombosis disease is: Radix Notoginseng is sterilized with 70% wine base, Radix Notoginseng after the sterilization adds water after with mechanical activation comminution and soak taste removal in 60-80 hour under 50-70 ℃ of temperature, be that the Chinese liquor normal pressure of 40%-60% soaked 100-200 hour with concentration after drying again, it is standby to leach liquid; Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii are sterilized with 70% wine base, slightly pulverize with jet mill afterwards, the Chinese liquor that adds concentration and be 40%-60% soaked 100-150 hour under 1.5-2.0 atmospheric pressure, under 0.6-0.8 atmospheric pressure, soaked 100-150 hour then, normal pressure soaked 100-200 hour again, and it is standby to leach liquid; With the Flos Carthami disinfection by ultraviolet light, be that the Chinese liquor normal pressure of 40%-60% soaked 200-400 hour with concentration then, it is standby to leach liquid.With the standby leaching liquid of Radix Notoginseng, the standby leaching liquid of Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii, the standby leaching liquid of Flos Carthami three hybrid filtering carries out esterification again, and finished product is made.
Use the medicated wine of the present invention's prevention and treatment cerebral thrombosis disease can prevent and treat the apoplexy and hemiplegia that causes by cerebral thrombosis, strong stalk; Prevention and treatment brain dementia, the excited lucidity of raising brain, the vigor and the efficient of raising brain; The treatment diabetic neuropathy, promoting blood circulation to restore menstrual flow, the anticoagulant blood fat reducing reduces blood viscosity, and antiplatelet aggregation and blood vessel dilating have the microcirculation improvement effect, promote nerve conduction; Prevent and delay the formation of old abnormal pigmentary deposit on the skin; The prevention women is because the facial abnormal pigmentary deposit on the skin formation that the menses imbalance causes; Prevention is because blood microcirculation is bad thereby produce the femur head necrosis that blood supply insufficiency causes; Prevention and treatment coronary heart disease prevent the acute sudden death of coronary heart disease; Amenorrhea dysmenorrhea due to the treatment women blood stasis, postpartum stagnation stomachache.
The specific embodiment
1, the specific embodiment of the medicated wine making of a kind of prevention of the present invention and treatment cerebral thrombosis disease:
Embodiment 1:
With dry weight is that the Radix Notoginseng of 50 grams sterilizes with 70% wine base, and the Radix Notoginseng after the sterilization adds water after with mechanical activation comminution and soak taste removal in 65 hours under 60 ℃ of temperature, adds concentration more after drying and be 2 liters of normal pressures immersions of Chinese liquor of 45% 130 hours, and leaching liquid is standby; With dry weight is that the Fructus Schisandrae Chinensis of 200 grams, the Fructus Lycii and the fresh weight of 100 grams are to sterilize with 70% wine base after 300 Fructus Crataegis that restrain mix, slightly pulverize with jet mill afterwards, adding concentration and be 45% Chinese liquor soaked 120 hours under 1.5 atmospheric pressure for 7 liters, under 0.6 atmospheric pressure, soaked 120 hours then, normal pressure soaked 130 hours again, and it is standby to leach liquid; With dry weight is the Flos Carthami disinfection by ultraviolet lights of 10 grams, is 1 liter of normal pressure immersion of 45% Chinese liquor 250 hours with concentration then, and leaching liquid is standby.With the standby leaching liquid of Radix Notoginseng, the standby leaching liquid of the standby leaching liquid of Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii and Flos Carthami three hybrid filtering carries out esterification again, makes the medicated wine of 10 liters of a kind of preventions and treatment cerebral thrombosis disease.
Embodiment 2:
With dry weight is that the Radix Notoginseng of 100 grams sterilizes with 70% wine base, and the Radix Notoginseng after the sterilization adds water after with mechanical activation comminution and soak taste removal in 75 hours under 60 ℃ of temperature, adds concentration more after drying and be 2 liters of normal pressures immersions of Chinese liquor of 55% 190 hours, and leaching liquid is standby; With dry weight is that the Fructus Schisandrae Chinensis of 400 grams, the Fructus Lycii and the fresh weight of 500 grams are to sterilize with 70% wine base after 300 Fructus Crataegis that restrain mix, slightly pulverize with jet mill afterwards, adding concentration and be 55% Chinese liquor soaked 130 hours under 2 atmospheric pressure for 7 liters, under 0.8 atmospheric pressure, soaked 130 hours then, normal pressure soaked 140 hours again, and it is standby to leach liquid; With dry weight is the Flos Carthami disinfection by ultraviolet lights of 40 grams, is 1 liter of normal pressure immersion of 55% Chinese liquor 240 hours with concentration then, and leaching liquid is standby.With the standby leaching liquid of Radix Notoginseng, the standby leaching liquid of the standby leaching liquid of Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii and Flos Carthami three hybrid filtering carries out esterification again, makes the medicated wine of 10 liters of a kind of preventions and treatment cerebral thrombosis disease.
Embodiment 3:
With dry weight is that the Radix Notoginseng of 80 grams sterilizes with 70% wine base, and the Radix Notoginseng after the sterilization adds water after with mechanical activation comminution and soak taste removal in 70 hours under 60 ℃ of temperature, adds concentration more after drying and be 2 liters of normal pressures immersions of Chinese liquor of 50% 150 hours, and leaching liquid is standby; With dry weight is that the Fructus Schisandrae Chinensis of 300 grams, the Fructus Lycii and the fresh weight of 400 grams are to sterilize with 70% wine base after 200 Fructus Crataegis that restrain mix, slightly pulverize with jet mill afterwards, adding concentration and be 55% Chinese liquor soaked 125 hours under 1.8 atmospheric pressure for 7 liters, under 0.7 atmospheric pressure, soaked 125 hours then, normal pressure soaked 150 hours again, and it is standby to leach liquid; With dry weight is the Flos Carthami disinfection by ultraviolet lights of 25 grams, is 1 liter of normal pressure immersion of 55% Chinese liquor 300 hours with concentration then, and leaching liquid is standby.With the standby leaching liquid of Radix Notoginseng, the standby leaching liquid of the standby leaching liquid of Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii and Flos Carthami three hybrid filtering carries out esterification again, makes the medicated wine of 10 liters of a kind of preventions and treatment cerebral thrombosis disease.
2, the specific embodiment of the medicated wine application of a kind of prevention of the present invention and treatment cerebral thrombosis disease:
Because of human body different to the sensitivity of wine and medicine, the body weight difference, ante cibum is different after meal, disease is different and different.What contain 50% alcohol concentration generally surpasses 120 milliliters at every turn, and excessive meeting infringement is healthy.Concrete application must be carried out under physician guidance.
Embodiment 1:
Zhu, 55 years old age, cerebral thrombosis, the medicated wine of a kind of prevention of two weeks drink the present invention after being ill and treatment cerebral thrombosis disease, every day 2 times, each 40 milliliters, the state of an illness is clearly better behind the drink two weeks.
Embodiment 2:
Gold certain, 77 years old, go hospital's intravenous drip every year, logical blood vessel, blood fat reducing was also lived institute because of thrombosis.After again aphasis taking place, the medicated wine of a kind of prevention of drink the present invention and treatment cerebral thrombosis disease 20 days, once a day, and each 100 milliliters, effect improved obvious, do not spend dead point.
Claims (2)
1, the medicated wine of a kind of prevention and treatment cerebral thrombosis disease, it is characterized in that: it is formed by the infusion of following proportion raw material medicine: Radix Notoginseng 5-10 gram, Fructus Schisandrae Chinensis 20-40 gram, Fructus Crataegi 10-30 gram, Fructus Lycii 30-50 gram, Flos Carthami 1-4 gram, 1 liter of 40%-60% Chinese liquor, described Fructus Crataegi is bright product weight, and all the other medicines are dry product weight.
2, the medicated wine of a kind of prevention as claimed in claim 1 and treatment cerebral thrombosis disease, it is characterized in that: Radix Notoginseng is sterilized with 70% wine base, Radix Notoginseng after the sterilization adds water after with mechanical activation comminution and soak taste removal in 60-80 hour under 50-70 ℃ of temperature, be that the Chinese liquor normal pressure of 40%-60% soaked 100-200 hour with concentration after drying again, it is standby to leach liquid; Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii are sterilized with 70% wine base, slightly pulverize then, the Chinese liquor that adds concentration and be 40%-60% soaked 100-150 hour under 1.5-2.0 atmospheric pressure, under 0.6-0.8 atmospheric pressure, soaked 100-150 hour then, normal pressure soaked 100-200 hour again, and it is standby to leach liquid; Flos Carthami is cleaned the back disinfection by ultraviolet light, is Chinese liquor normal pressure immersion 200-400 hour of 40%-60% with concentration then, and leaching liquid is standby; With the standby leaching liquid of Radix Notoginseng, the standby leaching liquid of the standby leaching liquid of Fructus Schisandrae Chinensis, Fructus Crataegi and Fructus Lycii and Flos Carthami three hybrid filtering carries out esterification again, promptly makes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100781089A CN100496562C (en) | 2004-09-16 | 2004-09-16 | Medicinal wine for preventing and treating cerebral thrombosis diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100781089A CN100496562C (en) | 2004-09-16 | 2004-09-16 | Medicinal wine for preventing and treating cerebral thrombosis diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1748750A CN1748750A (en) | 2006-03-22 |
CN100496562C true CN100496562C (en) | 2009-06-10 |
Family
ID=36604527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100781089A Expired - Fee Related CN100496562C (en) | 2004-09-16 | 2004-09-16 | Medicinal wine for preventing and treating cerebral thrombosis diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100496562C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108841516A (en) * | 2018-08-29 | 2018-11-20 | 何悦 | A kind of preparation method of west safflower health liquor |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009277111A1 (en) * | 2008-07-30 | 2010-02-04 | Nestec S.A. | Methods and compositions for preventing, reducing, or treating damage caused by ischemia and ischemia-like conditions |
CN102397285A (en) * | 2011-12-12 | 2012-04-04 | 新乡医学院 | Application of hyperin in preparation of medicines for resisting vascular dementia |
CN107997170B (en) * | 2017-11-30 | 2021-04-20 | 江苏康缘药业股份有限公司 | Composition with blood fat reducing function and preparation method thereof |
CN107998142B (en) * | 2017-12-16 | 2018-09-04 | 侯瑞玲 | A kind of combination of oral medication for treating myocardial ischemia-reperfusion injury |
CN111888410A (en) * | 2020-06-28 | 2020-11-06 | 王云 | Rehabilitation medicinal liquor |
-
2004
- 2004-09-16 CN CNB2004100781089A patent/CN100496562C/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
万能酒基-----高纯度酒精. 袁建成.酿酒科技,第99期. 2000 |
万能酒基-----高纯度酒精. 袁建成.酿酒科技,第99期. 2000 * |
酯化酶技术与白酒增香. 吴衍庸.酿酒科技,第95期. 1999 |
酯化酶技术与白酒增香. 吴衍庸.酿酒科技,第95期. 1999 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108841516A (en) * | 2018-08-29 | 2018-11-20 | 何悦 | A kind of preparation method of west safflower health liquor |
Also Published As
Publication number | Publication date |
---|---|
CN1748750A (en) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1085792A (en) | Treat bathomorphic liniment and preparation method thereof | |
CN104824254A (en) | Healthcare tea and making method thereof | |
CN101828715B (en) | Health-care food for patient with hyperlipidemia, hypertension and hypercholesterolemia | |
CN100422305C (en) | Male body building long life liquor | |
CN100496562C (en) | Medicinal wine for preventing and treating cerebral thrombosis diseases | |
CN101474310A (en) | Chinese medicine for beauty treatment and eliminating spot and preparation method | |
CN111558031B (en) | Pure plant multifunctional eye special nutrient solution and preparation method thereof | |
CN105213256A (en) | A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof | |
CN104414954A (en) | Snail skin cream for relieving allergy | |
CN101129956B (en) | Traditional Chinese medicine for treating rickets | |
CN109602832A (en) | A kind of Chinese medicine bathing antibacterial liquid/particle improving obstruction of the circulation of vital energy constitution and preparation and application method | |
CN101199673A (en) | Chinese medicine compound for treating light-headedness, eyes-drying and conjunctivitis and preparing method thereof | |
CN103652059B (en) | The formula of bagged medicine tea and preparation method | |
CN1124857C (en) | Chinese medicine prepn for treating cerebral thrombus, hypertension and cerebral arteriosclerosis and its production process | |
CN102973687B (en) | Oral liquid for regulating female hormonal balance | |
CN107158299A (en) | It is a kind of that there is composition of enhancing learning memory function and preparation method thereof | |
CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
CN102266481B (en) | Chinese medicinal preparation for treating chronic cerebral circulation insufficiency | |
CN1108809C (en) | Medicine for treating leukoderma and preparing process thereof | |
CN1846771A (en) | Spot-eliminating and physique strengthening composition | |
CN103549072A (en) | Vital energy-benefiting brain-boosting tea and preparation method thereof | |
CN102293940A (en) | Oral liquid for beautifying | |
CN101574478B (en) | Western and traditional Chinese medicine tincture for treating acne mark | |
CN106581362A (en) | Chinese patent medicine for treatment of neurasthenia and preparation method thereof | |
CN102641480A (en) | Traditional Chinese medicine composite used for treating microcirculation disturbance and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090610 Termination date: 20110916 |